mRNA-Based CRISPR/Cas9 Delivery for Gene Editing in Muscle Stem Cells
Time: 12:00 pm
day: Day One Track B AM
Details:
- Exploring muscle wasting and muscular dystrophy
- Assessing clinical trial, ATMP and regulatory considerations
- Advancing CMC and ex-vivo editing
